about
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine recep...
Read More
3.75
-0.08
(-2.09%)
57,880.4
XNAS Volume
XNAS 17 Jul, 2026 9:47 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
X4 Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..